Methyl-β-cyclodextrin Enhances Tumor Cellular Uptake and Accumulation of α-Linolenic Acid–Paclitaxel Conjugate Nanoparticles
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Meiqi Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Paclitaxel, beta-Cyclodextrins, Nanoparticles, alpha-Linolenic Acid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Improving nanomedicine uptake by tumor cells is key to achieving intracellular drug delivery. In this study, we found that methyl-β-cyclodextrin (MβCD) can significantly promote the intracellular accumulation of nanoparticulated α-linolenic acid-paclitaxel conjugates (ALA-PTX NPs) via enhanced clathrin-mediated endocytosis and limited degradation in lysosomes. Our in vitro results indicated that MβCD not only reduced the plasma membrane cholesterol content and increased plasma membrane fluidity, leading to ALA-PTX NPs being more easily incorporated into the plasma membrane, further enhancing membrane fluidity and making the plasma membrane more susceptible to tensile deformation, forming intracellular vesicles to enhance ALA-PTX NP cellular uptake, but also destroyed lysosomes and then limited ALA-PTX NPs' degradation in lysosomes. In HepG2 tumor-bearing mice, MβCD was also able to enhance the antitumor activity of ALA-PTX NPs in vivo. Moreover, we found that MβCD specifically promoted PUFA-paclitaxel conjugate NP cellular uptake. The cellular uptake of PTX liposome which shares an endocytosis pathway with ALA-PTX NPs could be enhanced by MβCD combined with ALA or ALA-PTX NPs. Therefore, we suggested that MβCD combined with polyunsaturated fatty acid-conjugation would be an effective strategy for improving intracellular delivery of nanoparticulated chemotherapeutic drugs used for combination administration to enhance antitumor efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou 310015, China.
- Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
ORCID-Profile: Meiqi Xu, Junwei Liu, Xuan Zhang
Förderung
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Xu, M., Liu, J., Yu, J., Wang, J., Li, H., Zhong, T., Hao, Y., Li, Z., Wang, J., Huang, X., Wang, H., Tian, Y., Zhao, H., Wei, Q., & Zhang, X. (2024). Methyl-β-cyclodextrin Enhances Tumor Cellular Uptake and Accumulation of α-Linolenic Acid–Paclitaxel Conjugate Nanoparticles. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00190
Vancouver
Xu M, Liu J, Yu J, Wang J, Li H, Zhong T, et al. Methyl-β-cyclodextrin Enhances Tumor Cellular Uptake and Accumulation of α-Linolenic Acid–Paclitaxel Conjugate Nanoparticles. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00190
BibTeX
@article{Xu2024,
author = {Xu, Meiqi and Liu, Junwei and Yu, Jianming and Wang, Jingwen and Li, Hui and Zhong, Ting and Hao, Yanli and Li, Zhuoyue and Wang, Jingru and Huang, Xu and Wang, Hui and Tian, Yubo and Zhao, Heng and Wei, Qingchao and Zhang, Xuan},
title = {Methyl-β-cyclodextrin Enhances Tumor Cellular Uptake and Accumulation of α-Linolenic Acid–Paclitaxel Conjugate Nanoparticles},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00190}
}
EUVIMED